ADVISORY/Novartis Oncology Submits Marketing Applications Globally For Glivec.Business Editors & Health/Medical Writers ADVISORY...for Thursday (March 1) NOTE TO EDITORS: Multimedia Assets Available With This Story Include Logos, Photos, Text News Releases, Video --(BUSINESS WIRE) Novartis Oncology is submitting applications with health authorities globally seeking marketing authorization for Glivec (formerly STI STI systolic time intervals. 571) for the treatment of patients with chronic myeloid leukemia myeloid leukemia n. See myelogenous leukemia. (CML 1. CML - A query language. ["Towards a Knowledge Description Language", A. Borgida et al, in On Knowledge Base Management Systems, J. Mylopoulos et al eds, Springer 1986]. 2. CML - Concurrent ML. ) in the blast crisis Blast crisis Stage of chronic myelogenous leukemia where large quantities of immature cells are produced by the marrow and is not responsive to treatment. , accelerated phase accelerated phase Oncology A progressive phase of CML characterized by immature, defective WBCs in BM and peripheral blood which is higher in the chronic phase, but less than in the blast phase. See Blast crisis. or in chronic phase after failure of interferon-alpha therapy. These filings, occurring within approximately one week of each other, continue the company's efforts to accelerate the rapid pace of this novel agent's global development. Submissions have taken place in the United States and the European Union, and the filing for Switzerland is expected within the week. The filing will be submitted in Japan and other countries shortly as well. You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?2226 This multimedia news story is for free and unrestricted use on your news information site (and for print or broadcast too). Visit http://www.newstream.com to download video, audio, text, graphics and photos. If you have any questions about the story, or about Newstream.com, please write to us at info@newstream.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion